New Zealand markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4416-0.0083 (-1.84%)
At close: 04:00PM EDT
0.4305 -0.01 (-2.51%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.97M
Enterprise value -73.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.20
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.31

Trading information

Stock price history

Beta (5Y monthly) 2.84
52-week change 3-75.44%
S&P500 52-week change 334.08%
52-week high 34.2980
52-week low 30.4120
50-day moving average 32.0380
200-day moving average 32.5775

Share statistics

Avg vol (3-month) 3772.18k
Avg vol (10-day) 3676.42k
Shares outstanding 538.44M
Implied shares outstanding 638.44M
Float 827.11M
% held by insiders 11.75%
% held by institutions 163.76%
Shares short (13 Sept 2024) 41.65M
Short ratio (13 Sept 2024) 41.05
Short % of float (13 Sept 2024) 46.08%
Short % of shares outstanding (13 Sept 2024) 44.28%
Shares short (prior month 15 Aug 2024) 4990.73k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-47.53%
Return on equity (ttm)-84.57%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -120.43M
Net income avi to common (ttm)-113.45M
Diluted EPS (ttm)-2.9700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)91.77M
Total cash per share (mrq)2.39
Total debt (mrq)1.41M
Total debt/equity (mrq)1.69%
Current ratio (mrq)3.97
Book value per share (mrq)2.17

Cash flow statement

Operating cash flow (ttm)-98.41M
Levered free cash flow (ttm)-68.05M